Ranbaxy to provide HIV/AIDS drugs to more nations

[Guest guest]

Ranbaxy to provide HIV/AIDS drugs to more nations

Ranbaxy Laboratories Ltd. announced on Tuesday that it is in talks with The

Jefferson Clinton Foundation to extend the scope of the agreement to

provide affordable HIV/AIDS drugs to more countries. This initiative is aimed at

bringing Anti Retroviral drugs (ARVs), now regarded as life-saving and essential

drugs, within the reach and easy access of millions of people suffering from HIV

and AIDS in many more countries, said Ranbaxy.

Presently, the agreement covers countries in Africa and the Caribbean regions

like, South Africa, Mozambique, Rwanda, Tanzania, Haiti, The Bahamas, Dominican

Republic, and The Organization of Eastern Caribbean States.

Around 1.5-2mn patients are estimated to benefit from this programme by 2008,

said Ranbaxy. The current arrangement covers fixed dose combination of

Triviro-LNS (Lamivudine+Stavudine+ Nevirapine), Aviro-LZN,

Lamivudine+Zidovudine+Nevirapine), Coviro (Lamivudine+ Stavudine), and

Efavirenz. These drugs are already available in several countries.

http://www.indiainfoline.com/news/news.asp?dat=37680